General information
    ACovPid:ACoVP100393
    Trivial Name:M-wt
    Amino Acids Sequence:KYEQYIKWPWYVWLGF
    Length:16
    C-Terminal Modification:None
    N-Terminal Modification:None
    Chemical Modification:None
    Peptide Source:

    Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009

    Source Description:
    Against Virus:

    Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009

    Inhibition Value Type:IC50
    Inhibitory Effect:26
    Inhibitory Unit:µM
    Target Domain Name:
    Assay:in Vitro assay
    Assay Description:The ability of MPER in both complementary interaction (with IFP) and self-interaction raised the possibility that MPER-derived peptides could serve as viral entry inhibitors. In principle, both MPER and IFP are exposed during viral entry, and their association with a MPERderived peptide could inhibit the progression of viral entry and infection. For safety reasons, the inhibitory activity of M-wt peptide was tested in neutralization assays using avian infectious bronchitis virus (IBV), instead of SARS-CoV. IBV contains the same MPER sequence and undergoes a fusion process synonymous to that of SARS-CoV. Specifically, the assay was conducted on recombinant IBV-Luc, which contains a firefly luciferase gene integrated at its ORF3a3b. Successful viral entry and subsequent replication of IBV-Luc were assessed by intracellular luciferase activity. The MPER peptide derived from IBV, M-ibv (LKTYIKWPWYVWLAIAF), was tested in parallel. Increasing concentrations of synthetic MPER peptides (0, 12, 25, and 50 µM) were mixed with IBV-Luc for 1 h at 37 °C and applied to Vero E6 cells seeded in a 96-well plate at 1 PFU. The peptide/virus mixture was removed 1 h postinfection. Cells were lysed 20 h postinfection, and luciferase activity was measured.
    Anti-CoV activity in vivo:
    Reference:25668103
    Comment:
    3D structure:

    StructureACoVP100393

    Structure Experiment Verified:NO
    Similar Peptides:ACoVP100218   ACoVP100228   ACoVP100242   ACoVP100246   ACoVP100250